Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FASgen receives NCI grant to support study of FAS inhibitors

April 13, 2004

Novel Bcl-XL antagonist effective against chemoresistant cancers in vivo

April 13, 2004

Enhanced tumor cytotoxicity with novel DNA-PK inhibitor

April 13, 2004

Novel small molecule tubulin inhibitor by Zentaris

April 13, 2004

New gossypol analogues and their use in cancer therapy reported by CNRS

April 13, 2004

MediGene extends clinical development of Polyphenon E to actinic keratosis

April 13, 2004

NeoRx acquires rights to AMD-473 from AnorMED

April 13, 2004

Aletheon acquires Pretarget intellectual property from NeoRx

April 13, 2004

Antiobesity drug effective against prostate cancer

April 13, 2004

Abbott's A-382535 demonstrates antiproliferative and apoptotic effects in human cancer cell lines

April 8, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...